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Letter to the Editor 
Clinical Microbiology
Persistent Bordetella petrii Infection Related to Bone 
Fractures
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Dear Editor,
Bordetella, of the family Alcaligenaceae, is a genus containing 
gram-negative coccoid rod species. To date, nine species have 
been assigned to the genus Bordetella [1]. Human infections 
caused by B. petrii have seldom been reported since its first de-
tection in 2001 [2-8]. Among seven reported cases, four were 
recovered from respiratory specimens [4-6, 8], while three were 
recovered from pus specimens of patients with bone-related in-
fections [2, 3, 7]. A 52-yr-old man without any medical history 
was admitted to a tertiary-care hospital (Hospital A) in Seoul, 
Korea, for tibia and fibula fractures of both legs. He had sus-
tained a crush injury to both legs on a riverboat in Thailand. He 
had undergone surgery and subsequently presented with puru-
lent discharge from the muscle flap site of the left leg. The 
wound culture revealed a gram-negative rod identified as Achro-
mobacter denitrificans by using a VITEK 2 GNI card (bioMéri-
eux, Marcy l’Etoile, France). After a month of managing the ab-
scess site, the patient was transferred to another hospital (Hos-
pital B) in Ilsan, Korea. At that hospital, deep tissue and bone 
cultures revealed the presence of Bordetella bronchiseptica and 
Alcaligenes species, respectively, using MicroScan (Dade Beh-
ring, West Sacramento, CA, USA). During a 15-month follow-
up, nonunion of fractured sites was observed. The patient was 
then admitted to our hospital (Hospital C) in Seoul, Korea, to 
undergo surgery for the delayed union. After discharge, his leg 
wound was managed at an outpatient clinic because his labora-
tory tests carried out three days after the surgery showed leuko-
cytosis (14×109/L) with elevated C-reactive protein (CRP) level 
(182.2 mg/L).
Deep wound culture yielded medium to large grayish and 
convex colonies that were non-hemolytic on sheep blood agar 
plate (BAP), and colorless, opaque pinpoint-sized colonies on 
MacConkey agar plate (isolate C1). Two serial follow-up cultures 
revealed the same species (isolates C2 and C3). Smear prepa-
ration of these colonies showed short gram-negative rods. Sub-
culture on triple-sugar iron slant agar showed that the bacteria 
did not ferment glucose or produce H2S. Isolates exhibited an 
umbrella-shaped growth pattern when cultured in motility-in-
dole-ornithine semisolid agar, suggesting that the microorgan-
ism is strictly aerophilic and motile. API 20NE (bioMérieux) and 
VITEK 2 GNI cards identified the isolates as A. denitrificans and 
Burkholderia species, respectively. However, matrix-assisted la-
ser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS; Bruker Daltonics, Billerica, MA, USA) identi-
fied them as B. petrii with a 2.089 score. The isolates were fi-
nally confirmed as B. petrii on the basis of partial sequences of 
the 16S rRNA gene, which showed 100% identity to those of 
DSM 12804, the type strain of B. petrii, when analyzed by 
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BLASTn (http://www.ncbi.nlm.nih.gov/BLAST). XbaI-macror-
estriction analysis was performed by using pulse field gel elec-
trophoresis (PFGE) (CHEF-DRII System, Bio-Rad, Hercules, CA, 
USA), as described previously [9]. All three clinical isolates ex-
hibited identical PFGE banding patterns (Fig. 1). 
Antimicrobial susceptibility testing (AST) was performed with 
the disk diffusion method. The minimal inhibition concentra-
tions (MICs) of antimicrobials were determined by Etest accord-
ing to the Clinical and Laboratory Standard Institute guidelines 
[10]. Clinical isolates C1-3 exhibited antimicrobial susceptibility 
patterns similar to those of the type strain DSM 12804. How-
ever, all three clinical isolates were resistant to cefepime and 
ciprofloxacin, while the type strain was susceptible to both drugs 
(Table 1). Cephalexin was used as empirical therapy and 
changed to levofloxacin following AST results. After two months 
of treatment, the wound infection was resolved with the normal-
ization of the white blood cell (WBC) count (9.22×109/L) and 
CRP level (3.3 mg/L). Isolates C1-3 may be clones because they 
exhibited identical antimicrobial susceptibility and PFGE band-
ing patterns. Former clinical isolates were identified as A. denit-
rificans, B. bronchiseptica, and Alcaligenes species in hospitals 
A and B. However, all these isolates are speculated to be B. 
petrii because commercially available cards misidentified our 
three clinical isolates and type strain DSM 12804 as A. denitrifi-
cans and Burkholderia species. Discrepancies among identifi-
cation methods have been reported previously [3, 5]. However, 
MALDI-TOF MS identified the isolates correctly with a high 
score. When bacterial culture results show discrepancies 
among different bacterial identification methods and the results 
include members of Alcaligenaceae, B. petrii should be sus-
pected and confirmed by using MALDI-TOF MS or 16S rRNA 
sequencing.
Here, B. petrii infection persisted for more than one year. 
Long-lasting B. petrii infections have been reported previously 
[5]. Chronic infections, despite continuous use of antibiotics, 
suggest the clinical difficulty of treating B. petrii. Bone-related in-
fections are associated with reduced effects of antimicrobial 
therapy, which possibly contribute to persistent B. petrii infec-
tion.
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